Procedural Sedation with Fentanyl and Midazolam

Introduction to Risks and Benefits

The combination of fentanyl and midazolam can be administered but requires close monitoring for respiratory depression, with appropriate training and equipment immediately available to manage potential respiratory complications 1

Mandatory monitoring requirements for patients receiving fentanyl and midazolam include continuous pulse oximetry, regular vital sign assessment, end-tidal CO2 monitoring when available, and dedicated personnel focused solely on monitoring the patient 1
Personnel trained in airway management must be present when administering fentanyl and midazolam, with immediate availability of age-appropriate resuscitation equipment and antagonists (naloxone for fentanyl, flumazenil for midazolam) 2

Reduced doses should be used when combining fentanyl and midazolam, with slow titration to effect rather than administering full doses at once, considering patient factors that increase risk (age, comorbidities, etc.) 1

The evidence regarding safety shows mixed but concerning findings, with some studies demonstrating increased respiratory depression risk, such as McQuillen and Steele's finding of significantly higher end-tidal CO2 increases with midazolam/opioid combinations versus midazolam alone 1
However, other studies, such as Pena and Krauss' large prospective series, found no increased risk of respiratory depression with the combination compared to other agents 1

Exercise additional caution in elderly patients, patients with respiratory conditions, debilitated patients, patients with renal or cardiac dysfunction, and patients undergoing upper airway procedures, as these populations may be at higher risk for respiratory complications 1